Company Filing History:
Years Active: 2015-2017
Title: The Innovations of Nicolas Anfossi
Introduction
Nicolas Anfossi is a notable inventor based in Francheville, France. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 2 patents, his work focuses on addressing critical health issues.
Latest Patents
Anfossi's latest patents include the development of Anti-KIR3D antibodies. This invention provides antigen-binding proteins capable of binding to KIR3D polypeptides. The antibodies demonstrate increased activity in treating disorders characterized by KIR3DL2-expressing cells, particularly CD4+ T cells. These disorders include malignancies such as Mycosis Fungoides and Sézary Syndrome.
Career Highlights
Nicolas Anfossi is currently associated with Innate Pharma, a company dedicated to advancing cancer immunotherapy. His work at Innate Pharma has positioned him as a key player in the biotechnology sector, contributing to innovative solutions for complex medical challenges.
Collaborations
Anfossi collaborates with esteemed colleagues, including Laurent Gauthier and Yannis Morel. These partnerships enhance the research and development efforts within his field, fostering a collaborative environment for innovation.
Conclusion
Nicolas Anfossi's contributions to biotechnology through his patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new therapeutic approaches in treating serious health conditions.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.